Orixone Plus 1000mg/500mg Injection
Marketer
Nexkem Pharmaceuticals Pvt Ltd
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Orixone Plus 1000mg/500mg Injection
Combiflox, a 1000mg/500mg injectable formulation, combats diverse bacterial infections. Its dual-action mechanism inhibits microbial proliferation and halts infection spread. Administration must be under a healthcare provider's guidance; strict adherence to the prescribed schedule is vital for efficacy. Complete the entire treatment course, even with symptom improvement, as premature cessation can compromise its effectiveness. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Escalating side effects necessitate immediate medical consultation. Seek immediate medical attention for allergic reactions (rash, pruritus, edema, dyspnea). Disclose all current medications to your physician before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential additive drowsiness. While generally not impairing driving ability, refrain from driving if experiencing somnolence or dizziness. Adequate rest, nutritious food, and hydration are crucial for optimal recovery. Your doctor may order lab tests to monitor the medication's impact.
Uses of Orixone Plus 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Orixone Plus 1000mg/500mg Injection:
This medication will be administered by your physician or registered nurse; please do not attempt self-medication.
Common Side effects of Orixone Plus 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Orixone Plus 1000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Orixone Plus 1000mg/500mg Injection works:
The injectable formulation, Orixone Plus 1000mg/500mg, unites Ceftriaxone, a bacterial growth inhibitor, with Sulbactam, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Sulbactam's role is to counteract bacterial resistance mechanisms, thereby boosting Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of Orixone Plus 1000mg/500mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Orixone Plus (1000mg/500mg) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or absent harm to the fetus; nevertheless, data from human studies remain scarce.
Breast feedingCAUTION
Administering Orixone Plus 1000mg/500mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Orixone Plus 1000mg/500mg Injection can induce drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Orixone Plus 1000mg/500mg Injection to individuals with renal impairment. Seek medical advice.
LiverCAUTION
The injectable formulation of Orixone Plus (1000mg/500mg) requires careful administration in individuals with advanced hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Orixone Plus (1000mg/500mg) injection is unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Orixone Plus 1000mg/500mg Injection :
Should you inadvertently skip a dose of the Orixone Plus 1000mg/500mg injection, seek advice from your physician.
Facts to Know About Orixone Plus 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently